{"id":"placebo-for-dccr","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL521875","moleculeType":"Small molecule","molecularWeight":"460.53"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with any biological pathways or receptors, and its primary purpose is to serve as a control in clinical trials.","oneSentence":"This drug is a placebo for DCCR, meaning it has no active therapeutic effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:59.939Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"DCCR-related conditions"}]},"trialDetails":[{"nctId":"NCT03714373","phase":"PHASE3","title":"Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period","status":"COMPLETED","sponsor":"Soleno Therapeutics, Inc.","startDate":"2018-10-01","conditions":"Prader-Willi Syndrome","enrollment":115},{"nctId":"NCT03440814","phase":"PHASE3","title":"A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome","status":"COMPLETED","sponsor":"Soleno Therapeutics, Inc.","startDate":"2018-05-09","conditions":"Prader-Willi Syndrome","enrollment":127},{"nctId":"NCT00973271","phase":"PHASE3","title":"Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides","status":"WITHDRAWN","sponsor":"Essentialis, Inc.","startDate":"2011-03","conditions":"Hypertriglyceridemia","enrollment":""},{"nctId":"NCT01211847","phase":"PHASE2","title":"Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia","status":"COMPLETED","sponsor":"Essentialis, Inc.","startDate":"2010-10","conditions":"Hypertriglyceridemia, Dyslipidemia","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo for DCCR","genericName":"Placebo for DCCR","companyName":"Soleno Therapeutics, Inc.","companyId":"soleno-therapeutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is a placebo for DCCR, meaning it has no active therapeutic effect. Used for DCCR-related conditions.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}